$11.640
+0.020 (+0.17%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ENTA Prediction & Forecast by Similar Chart Analysis
Alphio's ENTA stock price prediction model matches the current Enanta Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $11.51 (-1.13%). The 1-week path is $11.66 (+0.21%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Enanta Pharmaceuticals Inc Stock?
Enanta Pharmaceuticals is currently trading at $11.64, with a forward P/E ratio of 44.05, indicating that the stock may be overvalued based on future earnings expectations. The RSI is at 49.01, suggesting that the stock is neither overbought nor oversold, which means it may not be the best time to buy. The recent insider buying trend has increased by 137.44%, indicating some confidence from insiders, but the overall financial performance shows significant losses, with a net income loss of $19.5 million in the latest quarter. The main risk is the high forward P/E ratio, which suggests that the stock price may not be justified by future earnings potential, making it a hold for now.
ENTA stock price ended at $11.64 on Friday, after rising +0.17%
Enanta Pharmaceuticals Inc (ENTA) last closed at $11.64, gaining +0.17%. These facts feed the 1-day and 1-week ENTA price prediction above.
Analyst Consensus
Enanta Pharmaceuticals Inc (ENTA): 3 buy, 1 hold, 0 sell. Outlook: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Enanta Pharmaceuticals Inc (ENTA) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches ENTA, ranked by similarity.
Seasonality analysis for ENTA
Historically the probability of a positive October return for ENTA is 73.02%. November offers the highest probability of a positive month at 74.36%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for ENTA
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $3.46 | $4.36 | $4.59 | -62.55% |
| Nov 2026 | $3.53 | $4.36 | $4.76 | -62.55% |
| Dec 2026 | $4.56 | $5.46 | $6.29 | -53.05% |
In 2026, Enanta Pharmaceuticals Inc (ENTA) is projected to range from $3.46 to $6.29.
Enanta Pharmaceuticals Inc 2026 monthly forecast
In Oct 2026, Enanta Pharmaceuticals Inc is projected to average $4.36, with a low of $3.46 and high of $4.59.
In Nov 2026, Enanta Pharmaceuticals Inc is projected to average $4.36, with a low of $3.53 and high of $4.76.
In Dec 2026, Enanta Pharmaceuticals Inc is projected to average $5.46, with a low of $4.56 and high of $6.29.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.